Healthcare provider profile · identity verified

Sarah Baca, DNP, FNP-C

Nurse Practitioner · WEST LINN, OR · NPI 1902260425

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	269	85
Losartan Potassium	Losartan Potassium	175	52
Lisinopril	Lisinopril	168	52
Levothyroxine Sodium	Levothyroxine Sodium	160	41
Amlodipine Besylate	Amlodipine Besylate	120	40
Gabapentin	Gabapentin	114	38
Simvastatin	Simvastatin	86	33
Albuterol Sulfate Hfa	Albuterol Sulfate	83	40
Rosuvastatin Calcium	Rosuvastatin Calcium	79	23
Metoprolol Tartrate	Metoprolol Tartrate	77	19
Trazodone Hcl	Trazodone Hcl	77	27
Furosemide	Furosemide	76	23
Pantoprazole Sodium	Pantoprazole Sodium	73	28
Metformin Hcl	Metformin Hcl	61	23
Oxycodone Hcl	Oxycodone Hcl	61	18
Metoprolol Succinate	Metoprolol Succinate	58	18
Hydrochlorothiazide	Hydrochlorothiazide	57	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	19
Glipizide	Glipizide	49	19
Metformin Hcl Er	Metformin Hcl	48	19
Duloxetine Hcl	Duloxetine Hcl	46	17
Mirtazapine	Mirtazapine	45	13
Fluticasone Propionate	Fluticasone Propionate	44	11
Atenolol	Atenolol	43	13
Azelastine Hcl	Azelastine Hcl	43	20
Tamsulosin Hcl	Tamsulosin Hcl	42	16
Jardiance	Empagliflozin	41	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	39	34
Alendronate Sodium	Alendronate Sodium	38	25
Spiriva Respimat	Tiotropium Bromide	38	14
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Meloxicam	Meloxicam	36	19
Potassium Chloride	Potassium Chloride	35	19
Ozempic	Semaglutide	33	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	33	11
Triamcinolone Acetonide	Triamcinolone Acetonide	33	23
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	11
Humulin N Kwikpen	Insulin Nph Human Isophane	30	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Ketoconazole	Ketoconazole	27	22
Pregabalin	Pregabalin	26	13
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	16
Estradiol	Estradiol	23	14
Lorazepam	Lorazepam	23	12
Eliquis	Apixaban	22	suppressed
Sertraline Hcl	Sertraline Hcl	22	12
Allopurinol	Allopurinol	21	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	21	21
Naproxen	Naproxen	21	11
Omeprazole	Omeprazole	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Alvesco	Ciclesonide	16	11
Levetiracetam	Levetiracetam	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Mupirocin	Mupirocin	16	13
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Spironolactone	Spironolactone	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Hydrocortisone	Hydrocortisone	14	12
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	13	13
Topiramate	Topiramate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Montelukast Sodium	Montelukast Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Prednisone	Prednisone	12	suppressed
Retin-A	Tretinoin	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error